Thirty-seven percent of the respondents rated themselves as optimistic about the near-term future of U.S. healthcare.
Optimism about the near future of U.S. healthcare outpaced pessimism in the Managed Healthcare Executive® annual State of the Industry survey. But it wasn’t by the largest of margins.
Thirty-seven percent of the 450 respondents to the survey rated themselves as optimistic about the near-term future of U.S. health, although the milder “somewhat optimistic” group (23%) was larger than the very optimistic group (14%). Twenty-four percent were on pessimistic, 19% classifying themselves as somewhat pessimistic and just 5% rating themselves as very pessimistic.The largest group (39%0 occupied a middle ground and rated themselves as neutral.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
AGA Publishes Clinical Practice Update on Management of Pregnancy-Related GI and Liver Disease
December 18th 2024It is known that patients with active IBD have an increased risk of preterm birth, slowed fetal growth, low birth weight, hypertensive disease of pregnancy, and cesarean birth. On the other hand, conception during disease remission results in similar relapse rates as for people with IBD who are not pregnant.
Read More